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ABSTRACT We have constructed an 8-base-pair insertion
mutation in the 3' noncoding region of an infectious poliovirus
cDNA clone that gives rise to a temperature-sensitive RNA
synthesis mutant upon transfection into mammalian cells. The
mutated cDNA was used to establish a cell line that releases the
mutant poliovirus in a temperature-dependent fashion, repre-
senting a unique persistent viral infection. A poliovirus mutant
mapping in the noncapsid region of the viral genome can be
complemented in this cell line, implying that the cell line
expresses viral proteins at the nonpermissive temperature.
Many events take place in a cell infected by poliovirus. The
positive-strand RNA genome of the virus must be replicated,
viral proteins made, cellular functions inhibited, and new
virions produced. Although much has been learned about
these and other aspects of the virus life cycle (1), clear
understanding of the functions of the various viral proteins
and their interaction with cellular constituents still lies ahead.
This is due in part to the lack of well-defined poliovirus
mutants.
The discovery that a cloned cDNA copy of the poliovirus
RNA genome gives rise to infectious poliovirus upon
transfection into mammalian cells (2, 3) opened up the
possibility of constructing defined poliovirus mutants by
mutagenizing the infectious cDNA. The opportunity to store
the genetic information encoding a mutant poliovirus as a
cDNA clone makes it possible to determine the nucleotide
sequence of the mutated genome and to ensure that the
mutation is responsible for the observed phenotype.
We report here the construction of several linker-insertion
mutations in the 3' noncoding region ofthe viral genome. One
of these mutations, PIH7387, gave rise to a temperature-
sensitive poliovirus mutant. The infectious cDNA bearing
this mutation was used to establish stable persistently infect-
ed human HeLa cell lines that release infectious poliovirus at
the permissive temperature. Such cell lines, at the non-
permissive temperature, can complement another poliovirus
mutant, showing that the integrated viral genome is translat-
ed.
MATERIALS AND METHODS
Cells and Viruses. HeLa cells were maintained in suspen-
sion culture in Joklik's modification of minimal essential
medium (MEM) supplemented with 7% horse serum
(GIBCO). CV1 cells were grown in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10o fetal calf
serum (Hazleton). Wild-type poliovirus was isolated from a
single plaque derived from HeLa cells transfected with a
pSV2-polio plasmid as described (2). Protocols for prepara-
tion of virus stocks and viral infections have been described
(4).
Bacterial Strains and Plasmids. Escherichia coli strain
HB101 was the host for all plasmids used and was obtained
from C. Cepko (Harvard Medical School). Plasmid pSV2-
polio was originally obtained from V. R. Racaniello (Colum-
bia University). Plasmid pUC9 was purchased from Bethesda
Research Laboratories.
Enzymes. Restriction endonuclease enzymes were pur-
chased from New England Biolabs. Klenow enzyme and T4
DNA ligase were obtained from Boehringer Mannheim.
Construction of Linker-Insertion Mutations. Plasmid
pSV2-polio was digested to completion with EcoRI and
HindIII. The DNA fragments were separated by low-melting
agarose (Sigma) gel electrophoresis. The gel piece containing
the 978-base-pair (bp) EcoRI/HindIII fragment (see Fig. 1)
was excised with a razor blade and melted at 680C for 15 min.
After sequential extractions with phenol and chloroform/
isoamylalcohol (24:1, vol/vol), the DNA fragment was pre-
cipitated with ethanol and stored at -200C. The vector pUC9
was digested with EcoRI and HindIII, extracted with phenol,
and precipitated with ethanol. Equimolar amounts of thc
digested vector pUC9 and the 978-bp fragment were ligated
overnight at 150C (5). The ligation mixture was transformed
into HB101 and the recombinant pUC-polio was isolated
using an alkaline minipreparation of bacterial cultures ob-
tained from single bacterial colonies (6). The pUC-polio
plasmid was then digested with Taq I in the presence of
ethidium bromide in order to increase the number of mole-
cules containing only one double-stranded break (7), and
full-length linear molecules were isolated by low-melting
agarose gel electrophoresis. Linear molecules (1 ,ug) were
resuspended in 20 ,ul of 50 mM Tris HCl pH 7.6/50 mM
NaCl/1 mM dithiothreitol/2 mM dNTPs. The single-stranded
5' termini were repaired by addition of 5 units of Klenow
enzyme for 30 min at room temperature. The reaction was
stopped by adding NaDodSO4 to a final concentration of
0.1%, followed by heating at 68°C for 5 min, phenol extrac-
tion, and precipitation with ethanol. The DNA molecules
were either religated alone, to create 2-bp insertions, or after
the addition of phosphorylated Hpa I or Xho I-linker oligo-
mers (Collaborative Research, Waltham, MA) (5). Ligated
molecules were transformed into HB101 and screened for
recombinants that had either lost the targeted Taq I restric-
tion endonuclease site or had acquired a new Hpa I or Xho
I site at that position. The EcoRI/HindIII fragments of the
pUC-polio subclones were prepared as described above and
ligated with the 9028-bp HindIII/EcoRI DNA fragment
prepared from the wild-type pSV2-polio plasmid. In this way,
plasmids were obtained bearing a 2-bp insertion (PTF7387),
Abbreviation: bp, base pair(s).
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an 8-bp insertion (PTH7387), or a 10-bp insertion (PTX7387)
at the Taq I restriction endonuclease site at nucleotide
position 7387 of the viral genome. Predicted nucleotide
sequence was verified by sequencing the 978-bp EcoRIl
HindIII fragment (8).
Construction of Persistently Infected Cell Lines. Persistently
infected HeLa cell lines were constructed by cotransfection
of PTH7387 and pSV2-neo at a molar ratio of 20:1 using the
calcium phosphate coprecipitation method (9). At 4 hr after
transfection, cells were shifted to 39.50C and maintained at
this temperature. The drug G418 (GIBCO) was added to the
medium 48 hr after transfection according to the protocol of
Southern and Berg (10). At 18 days after transfection,
individual G418-resistant colonies were cloned and grown in
duplicate at 39.50C and 320C. Of 136 cloned cell lines, 12
released PTH7387 at 320C within 3 days after the temperature
shift. Representative persistently infected cell lines that were
examined further were designated numbers 35 and 40. As a
control cell line, we selected a G418-resistant line that does
not contain poliovirus cDNA sequences, termed cell line 107.
RESULTS
Construction of Linker-Insertion Mutations in the
Poliovirus cDNA 3' Noncoding Region. As part of a more
general program of linker-insertion mutagenesis of an infec-
tious poliovirus cDNA clone, we chose to insert linkers in
Taq I sites near the 3' end of the viral genome (Fig. 1). The
pSV2-polio plasmid, containing polio cDNA and a simian
virus 40-derived promoter (11), has 17 Taq I sites, so we
subcloned a 978-bp HindIII/EcoRI fragment into the unique
HindIII and EcoRI sites of the plasmid pUC9 (12). The
pUC-polio plasmid contained five Taq I sites, one within the
ampicillin-resistance gene, one in the 3' untranslated region
of the cDNA, and three in coding sequences. The recombi-
nant plasmid was partially digested with Taq I and full-length
linear DNA molecules were isolated. These molecules,
containing 2-bp 5' overhangs resulting from the Taq I diges-
tion, were filled in at both ends with the Klenow fragment of
DNA polymerase (5) and recircularized by ligation with DNA
ligase, either immediately or after addition ofDNA oligomers
containing either 6-nucleotide bps of an Hpa I site or
8-nucleotide bps including an Xho I site. The plasmids
containing insertions at the Taq I site in the 3' noncoding
region (position 7387) were identified by restriction endonu-
clease digestions and their HindIII/EcoRI fragments were
isolated and relegated to the largest fragment of a
HindIII/EcoRI partial digest of the pSV2-polio plasmid.
Recombinant full-length cDNA clones were obtained bearing
2-bp (PTF7387), 8-bp (PTH7387), or 10-bp (PTX7387) inser-
tions in the 3' untranslated region at nucleotide position 7387
(Fig. 2).
Phenotype of Poliovirus Mutants Mapping in the 3' Noncod-
ing Region. Wild-type and linker-insertion-mutagenized
pSV2-polio plasmids were transfected into HeLa cells by the
DEAE-dextran transfection procedure (16) and were scored
for the formation of poliovirus plaques at 32°C and 39.5°C.
The cDNAs containing a 2-bp or a 10-bp insertion at position
7387 gave rise to plaques of wild-type size, and the yields of
viruses were identical to wild-type at both temperatures. In
contrast, the 8-bp Hpa I linker-containing cDNA (PTH7387)
produced plaques only at 32°C. Virus stocks were prepared
from such plaques and characterized for growth at both
temperatures (Table 1). PTH7387 was clearly extremely
temperature sensitive for growth. It grew equally well in
human HeLa cells and in African green monkey kidney cells
(CV1) at 32TC, but at 39.50C it produced <0.1% of the yield
at permissive temperature. Furthermore, plaques picked at
the restrictive temperature displayed wild-type phenotypes,
suggesting that they were revertants.
To ensure that the mutated cDNA contained the predicted
alteration and that this alteration was responsible for the
phenotype, we determined from the nucleotide sequence of
a DNA fragment spanning the 3' noncoding region that the
8-bp insertion was the only change present. This fragment
was then cloned into an unmutagenized vector and shown to
reproduce the mutant phenotype when transfected into
mammalian cells. This "mix-and-match" experiment exclud-
ed the possibility that accidental second-site mutations ac-
quired during the cloning procedures were responsible for the
observed phenotype.
Establishment of a Cell Line Persistently Infected with a
Mutant Poliovirus cDNA. PTH7387 makes <5% ofthe normal
yield of viralRNA at the restrictive temperature (unpublished
data). It might, therefore, not be able to spread through a cell
population at all at 39.50C. Should this be true, cells harboring
the PTH7387 plasmid might be able to grow normally at
39.50C but would yield virus when grown at 32TC. To examine
this possibility, we cotransfected HeLa cells with the mutant
plasmid along with a plasmid bearing the dominant selectable
marker for G418 resistance (10) at a molar ratio of 20:1.
Transfected cells were grown at 39.50C and G418-resistant
colonies were selected. At 18 days after transfection, the
individual colonies were cloned and grown in duplicate at
39.50C and 32TC. Of 136 cloned cell lines, 12 released
poliovirus at 32TC during 3 days after the temperature shift.
The supernatants of these producer cell lines were harvested
and plaque assays were performed at both temperatures. The
virus released by these cell lines had the same temperature
sensitivity as the original mutant (data not shown). These
results indicated that we had derived cell lines that harbored
the intact mutant viral cDNA but allowed recovery of
infectious poliovirus in a temperature-regulated fashion,
representing a unique persistent viral infection.
To study the persistently infected cells further, we con-
centrated on two lines: a line designated cell line 40 that
released virus on temperature downshift and had a single
integrated copy of the PTH7387 plasmid (data not shown),
and control line 107, which was G418 resistant but did not
release virus after downshift and had no detectable integrated
poliovirus sequences (data not shown). To examine the
production of virus by individual cells after downshift, we
overlaid dishes of confluent cells with agar and shifted some
dishes to an incubation temperature of 32°C. After 3 days at
39.5°C or 5 days at 32°C, viable cells were stained with crystal
violet. Neither line produced any plaques at 39.5°C (Fig. 3A)
but cell line 40 produced many plaques of heterogeneous size
at 32°C (Fig. 3B), while line 107 did not. When the lines were
infected with wild-type virus at 39.5°C, they produced equal
numbers of large, quite homogeneous plaques (Fig. 3C).
Thus, both lines are permissive for growth of wild-type virus
at 39.5°C but line 40 has the unique capability to yield plaques
at 32°C. The inhomogeneity of plaque size produced by line
40 at 32°C suggests that initial virus release is asynchronous;
an increasing number of plaques seen with increased time of
incubation is consistent with this interpretation (data not
shown). Only a few hundred cells of the -5 x 106 on the dish
yielded a plaque, suggesting that virus activation is a rela-
tively rare event.
Complementation of a Poliovirus Mutant in the Persistently
Infected Cell Line 40. Recently it has been shown that several
poliovirus mutants can effectively complement each other
(ref. 17; H.D.B. and D.B., unpublished observations). Some
of the complementable mutations map outside of the capsid
region of the poliovirus genome, suggesting that some
noncapsid poliovirus proteins can function in trans during the
infectious cycle. This result encouraged us to attempt to
complement a poliovirus mutant in persistently infected cell
line 40 at the nonpermissive temperature. We chose a mutant
that might be sensitive to small amounts of poliovirus protein
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and, therefore, would represent a sensitive assay of
complementation. To this end, we chose to complement a
small plaque mutant, termed HF121, which maps in the
P2-2A region of the poliovirus genome and is deficient in the
selective inhibition of host protein synthesis, a function that
can be provided by small amounts of protein made very early
in infection (4).
The complementation experiment was done by infecting
either nonproducer cell line 107 (Fig. 4A), or producer cell
FIG. 1. Strategy for the construction of linker-
insertion mutants in the poliovirus cDNA. The pSV2-
polio plasmid contains pBR322 sequences (open bar),
the simian virus 40 promoter and enhancer elements
(box), and polio-cDNA (solid bar). The open triangles
point to the Taq I restriction endonuclease site present
in the plasmid. The solid triangle represents a mutated
Taq I site. Hatched bars show the added linker oligo-
mers. Construction of the recombinants is described in
Materials and Methods. ampR, Ampicillin resistance;
kb, kilobases; HIII, HindIII.
line 40 (Fig. 4 B and C), with the mutant HF121 or wild-type
poliovirus. The infected cell lines were overlaid with agar and
incubated at 39.50C for various lengths of time. The culture
dishes were then stained with crystal violet and scored for
plaques.
The HF121 mutant produced only very tiny plaques on cell
line 107 (Fig. 4A), as it does on uncloned HeLa cells.
However, when plated on cell line 40, HF121 formed signif-
icantly larger plaques (Fig. 4B), although still not wild-type
MAHONEY TAG TAA CCC TAC CTC AGT |GA ATT GGA TTG GGT CAT ACT GTT GTA GGG GTA AAT TTT TCT TTA ATT CGG AGA-polyA
SABIN i TAG TAA CCC TAC CTC AG T CGA ATT GGA TTG GGT CAT ACT GCT GTA GGG GTA AAT TTT TCT TTA ATT CGG AGG- polyA
SABIN 2 TAG TAA CCC TAC CTC AGT CGA ATT GGA TTG GGT CAT ECT GTT GTA GGG GTA AAT TTT TCT TTA ATT CGG -GA- polyA
SABIN 3 TAG TAA CCC TAC CTC AG ATT GGA TTG GGT CAT PCT GTT GTA GGG GTA AAT TTT TCT TTA ATT CGG AGG- polyA
TAQI \
PLASMID CONSTRUCTION INSERTION STRUCTURE PHENOTYPE
pSV2-polio None
pTF 7387 Klenow
pTH 7387 Hpal-Linker
pTX 7387 Xhol- Linker
TCGA
2 bp TCG CGA
8bp TCGGTTAACCGA
10 bp TCGCCTCGAGGcGA
FIG. 2. Poliovirus mutants mapping in the 3' noncoding region. The nucleotide sequences of the Mahoney and Sabin strains are shown
(13-15), with individual nonconserved nucleotides marked. The mutagenized Taq I restriction endonuclease site is indicated by a large box.
Designation of wild-type (W.T.) phenotype means that the yield of the particular virus in a single-cycle infection is the same as wild-type
poliovirus. Temperature-sensitive (T.S.) phenotype denotes that the virus yield of PTH7387 in a single-cycle infection at the nonpermissive
temperature is 0.1% of the wild-type yield.
W.T.
W.T.
T.S.
W.T.
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Table 1. Titer of wild-type poliovirus and temperature-sensitive PTH7387 virus stocks
Wild type PTH7387
39.5 0/ 39.5(C/
Cell line 320C 39.50C 320C 320C 39.50C 320C
HeLa 2.5 x 109 3 x 109 1.2 5 x 109 2 x 106 4 x 10-4
CV1 4 x 108 6 x 108 1.5 9 x108 2 x 105 2 x 10-4
Plaque assays were performed at the temperatures indicated and the virus titers are displayed as
plaque-forming units of virus stock per ml.
size plaques (Fig. 4C). We suggest that this increase in plaque
size represents complementation of the HF121 mutant in cell
line 40. In another line that produces poliovirus after temp-
erature downshift, cell line 35, HF121 also produced larger
plaques.
Another possible explanation for the faster growth of
HF121 in cell line 40 could be the formation of viral
recombinants that overgrew the small plaque mutant viruses.
To examine this possibility, we picked 20 plaques from the
HF121-infected cell line 40 and assayed virus from each
plaque on HeLa cells at 320C and 39.5°C. Virus from all 20
plaques displayed the mutant small-plaque phenotype at all
temperatures (not shown). In addition, the titers at both
temperatures were the same indicating that little or no
endogenous viral RNA derived from pSVPTH7387 had been
rescued.
In a different kind of complementation experiment, we
tested the virus yield during single-cycle infections of cell
lines 107 and 40. The yield and growth curve of wild-type
virus was the same in both cell lines. Mutant HF121 grew
more slowly in both cell lines, but its yield was 10 times higher
from line 40 than from line 107 (Fig. 5). Thus, cell line 40
apparently produces sufficient poliovirus products to com-
plement at least one poliovirus mutant.
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DISCUSSION
We report here the construction of a poliovirus mutant
mapping in the 3' noncoding region of the viral genome. The
mutant was obtained by site-directed mutagenesis of an
infectious cDNA clone using linker insertion at a known
restriction endonuclease site. Having a cDNA copy of the
mutation enabled us to perform "mix-and-match" experi-
ments with DNA fragments bearing the desired mutation to
unambiguously map the introduced mutation and the mutant
phenotype to a single locus in the viral genome. Although we
have not formally proven that the introduced mutation is
present in the viral RNA genome, it is unlikely that other
changes occur in the viral RNA molecule eliciting the mutant
phenotype because every plaque isolate derived from the
transfected mutated cDNA gives rise to the same tempera-
ture-sensitive mutant phenotype.
We chose the 65-nucleotide-long 3' noncoding region as a
target for mutagenesis because it contains highly conserved
sequences that might, for instance, be involved in the
initiation of minus-strand RNA synthesis. Despite the fact
that only three nucleotide changes (at positions 7405 and
7409) are found in this region among the three poliovirus
strains (Fig. 2) (13-15), nucleotide insertions at the Taq I site
at position 7387 are tolerated. Mutants with 2- (PTF7387) or
10- (PTX7387) nucleotide insertions produced virus yields
similar to wild-type virus, indicating that sequences 5' and 3'
of this insertion need not be contiguous to provide their
function. That an 8-nucleotide insertion at the same site gave
rise to a conditional lethal mutant (PTH7387) is remarkable.
Perhaps the RNA genome of PTH7387 folds properly at the
permissive temperature but may contain a different second-
ary structure at the restrictive temperature and be unable to
function. Temperature-dependent mutants of RNA mole-
cules that affect the biological function of the nucleic acid
have been described in tRNA (18, 19) and in mitochondrial
rRNA (20, 21).
The very strong temperature sensitivity of PTH7387 al-
lowed us to produce a unique type of persistently infected
cell. Persistently infected cells with poliovirus have been
described (22-24) but were presumably based on slow repli-
cation of viral RNA rather than on storage of the genome as
a DNA copy (25). A previous claim of persistence of
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FIG. 3. Temperature-dependent spread of PTH7387 poliovirus in
persistently infected cell line 40. Cell line 40 was overlaid with agar
and (A) incubated at 39.5°C or (B) shifted to an incubation temper-
ature of 320C. After 3 days at 39.5°C or 5 days at 32°C, the dishes were
stained with crystal violet and scored for plaques. (C) In a control
experiment, cell line 40 was infected with wild-type virus, overlaid
with agar, and incubated for 3 days at 39.5°C.
B C
FIG. 4. Complementation of poliovirus mutant HF121 in persis-
tently infected cell line 40. (A) Nonproducer cell line 107 and (B)
persistently infected cell line 40 were infected with HF121, overlaid
with agar, and incubated for 4 days at 39.5°C. (C) In addition, cell line
40 was infected with wild-type virus and incubated at 39.50C for the
same length of time. The dishes were stained with crystal violet.
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FIG. 5. Growth curves ofwild-type and mutant-HF121 poliovirus
in persistently infected cell line 40 and control cell line 107. Plates
containing 5 x 10' of the indicated cells were infected with wild-type
or HF121 virus at a multiplicity of 5 plaque-forming units (pfu) per
cell. Cells were harvested at the indicated times, virus stocks were
prepared, and virus titer was determined by plaque assay on HeLa
cells. The titers are plotted semilogarithmically as a function of time
after infection. o, Wild-type poliovirus; e, HF121 mutant.
nonretrovirus RNA viruses through a DNA copy has not
been substantiated (26). Retroviruses, of course, use the
same strategy but are much more efficient in that they
continually produce virus from all persistently-infected cells.
Poliovirus, being lytic in its growth, and released by cell lysis,
cannot both grow and be maintained in the same cell.
Therefore, there may be selection against high expression
during the establishment of the cell lines because poliovirus
encodes powerful inhibitors of cellular protein synthesis and
transcription, which might produce lethality at low levels. So
far, we were unable to detect poliovirus-specific RNA in the
persistently infected cells by RNA blot analysis (5) of total
cellular RNA.
To examine whether there is any expression of the viral
genome, we used the sensitive tool of complementation. We
infected a persistently infected cell line with mutant HF121.
This mutant is very tight, producing only very small plaques
on HeLa cells at any temperature. The mutation is located in
protein 2A (also called protein 8; ref. 27) and fails to
selectively inhibit cell protein synthesis. It is known to be
complemented by many other poliovirus mutants (H.D.B.
and D.B., unpublished observations). Its complementation in
cell lines 40 and 35 indicates that they produce at least a little
viral protein in some cells. The complementing protein would
be one involved in inhibition of cellular protein synthesis.
Whether there is some selective inhibition of cellular protein
synthesis in the persistently infected cells is not clear.
Preliminary experiments showed that the cap-binding com-
plex protein P220 (28) is cleaved at low levels in the
persistently infected cell lines. This cleavage might facilitate
the cap-independent translation of the mutant RNA mole-
cules. Alternatively, protein 2A might have multiple func-
tions, and the complementing activity might not involve
inhibition of cellular protein synthesis.
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